SARS-CoV-2 infects multiple species of North American deer mice and causes clinical disease in the California mouse
J. Lewis, S. Zhan, A. Vilander, A. C. Fagre, H. Kiaris, T. Schountz
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes coronavirus disease-19 (COVID-19), emerged in late 2019 in Wuhan, China and its rapid global spread has resulted in millions of deaths. An important public health consideration is the potential for SARS-CoV-2 to establish endemicity in a secondary animal reservoir outside of Asia or acquire adaptations that result in new variants with the ability to evade the immune response and reinfect the human population. Previous work has shown that North American deer mice (Peromyscus maniculatus) are susceptible and can transmit SARS-CoV-2 to naive conspecifics, indicating its potential to serve as a wildlife reservoir for SARS-CoV-2 in North America. In this study, we report experimental SARS-CoV-2 susceptibility of two additional subspecies of the North American deer mouse and two additional deer mouse species, with infectious virus and viral RNA present in oral swabs and lung tissue of infected deer mice and neutralizing antibodies present at 15 days post-challenge. Moreover, some of one species, the California mouse (P. californicus) developed clinical disease, including one that required humane euthanasia. California mice often develop spontaneous liver disease, which may serve as a comorbidity for SARS-CoV-2 severity. The results of this study suggest broad susceptibility of rodents in the genus Peromyscus and further emphasize the potential of SARS-CoV-2 to infect a wide array of North American rodents. ImportanceA significant concern is the spillback of SARS-CoV-2 into North American wildlife species. We have determined that several species of peromyscine rodents, the most abundant mammals in North America, are susceptible to SARS-CoV-2 and that infection is likely long enough that the virus may be able to establish persistence in local rodent populations. Strikingly, some California mice developed clinical disease that suggests this species may be useful for the study of human co-morbidities often associated with severe and fatal COVID-19 disease.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- North American deer mice are susceptible to SARS-CoV-2
B. D. Griffin, M. Chan, … D. Kobasa·Nature CommunicationsPeer-reviewed·Jun 14, 2021
- SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for reverse zoonosis to New World rodents
A. Fagre, J. Lewis, … T. Schountz·bioRxiv·Aug 7, 2020
- Survey of peridomestic mammal susceptibility to SARS-CoV-2 infection
A. Bosco-Lauth, J. J. Root, … R. A. Bowen·bioRxiv·Jan 21, 2021
- Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2
M. V. Palmer, M. Martins, … D. G. Diel·bioRxiv·Jan 13, 2021
- Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses
R. Earnest, A. M. Hahn, … N. D. Grubaugh·bioRxiv·Sep 22, 2023
- SARS-CoV-2 virus infection of Peromyscus leucopus demonstrates that infection tolerance is not limited to agents for which deermice are reservoirs
Ana Milovic, Johannes S. Gach, … Alan G. Barbour·bioRxiv·May 3, 2026